Journal of Ayurveda and Integrated Medical Sciences

2024 Volume 9 Number 12 DECEMBER
Publisherwww.maharshicharaka.in

Effect of Draksha Samangadi Kashaya Ghan Vati in Adolescents with Psychological Distress - A Double Blind Randomized, Placebo Controlled Trial

Rathi K1*, Sharma BD2, Ojha NK3
DOI:10.21760/jaims.9.12.5

1* Kavita Rathi, Post Graduate Scholar, Department of Kaumarbhritya, National Institute of Ayurveda, Jaipur, Rajasthan, India.

2 Brahm Dutt Sharma, Assistant Professor, Department of Kaumarbhritya, National Institute of Ayurveda, Jaipur, Rajasthan, India.

3 Nisha Kumari Ojha, Professor and HOD, Department of Kaumarbhritya, National Institute of Ayurveda, Jaipur, Rajasthan, India.

Aim of study: A double blind randomized, placebo-controlled trial was planned to evaluate the Clinical efficacy of Draksha Samangadi Kashaya Ghan Vati an Ayurveda multi-dimensional herb preparation in Adolescents suffering with Psychological Distress. The trial drug contains Draksha, Samanga, Gavakshi, Trayamana, Yashtimadhu, Chandana, Maricha, Pippali, Shunthi. All ingredients of the study drug possess anti-stress, anti-depression, anti-anxiety, nootropic and anti-oxidant properties.

Materials and Methods: A total of 40 patients complected the trial, including male and female patients, were studied for suffering of Psychological Distress and were registered and divided into 2 groups (Group A, B,). In group A, patients were administered Draksha Samangadi Kashaya Ghan Vati, dose 500 mg/day twice a day for 2 months in children suffering from Psychological Distress. In group B, Placebo - Chocolate Coated Starch Tablets were administered to 20 patients at a dose of 500 mg/day. All the treated cases were assessed at each follow-up on the 14th day, 28th day, 42nd day, and 56th day, and post-follow-up was done after 1 month. The efficacy of drugs was assessed clinically and also based on Depression, anxiety and stress scale (DASS 42).

Result: Group A consistently shows significant improvements across all three psychological conditions (Depression, Anxiety, and Stress) compared to Group B.

Conclusion: Draksha Smangadi Kashaya Ghan Vati (Chocolate Coated) is effective in the management of Psychological Distress in Adolescents.

Keywords: Draksha Samangadi Kashaya Ghan Vati, Trayamana, Yashtimadhu, Chandana, Maricha, Pippali, Shunthi

Corresponding Author How to Cite this Article To Browse
Kavita Rathi, Post Graduate Scholar, Department of Kaumarbhritya, National Institute of Ayurveda, Jaipur, Rajasthan, India.
Email:
Rathi K, Sharma BD, Ojha NK, Effect of Draksha Samangadi Kashaya Ghan Vati in Adolescents with Psychological Distress - A Double Blind Randomized, Placebo Controlled Trial. J Ayu Int Med Sci. 2024;9(12):41-49.
Available From
https://jaims.in/jaims/article/view/3886

Manuscript Received Review Round 1 Review Round 2 Review Round 3 Accepted
2024-11-14 2024-11-25 2024-12-04 2024-12-13 2024-12-21
Conflict of Interest Funding Ethical Approval Plagiarism X-checker Note
None Nil Yes 12.65

© 2024by Rathi K, Sharma BD, Ojha NKand Published by Maharshi Charaka Ayurveda Organization. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/ unported [CC BY 4.0].

Download PDFBack To ArticleIntroductionAim and ObjectiveMaterials and MethodsObservation and ResultsDiscussionConclusionReferences

Introduction

The word adolescent comes from Latin verb adolescent meaning “To grow up. According to WHO adolescents lies in between 10-19 years of age.[1] Because of physical, psychological, and sexual changes that occur during adolescence, psychiatric complaints like depression, anxiety, and stress occurs during this phase of life is a cause for alarm. The world’s highest population of adolescents live in India that is 253 million and every 5th individual is in middle of 10 to 19 years.[2] In adolescent term psychiatric morbidity is defined as abnormality in relationship, emotions, general behavior and activity which is developmentally inapt and responsible for persistent suffering or handicap adolescents and/or distress to households or society. Adolescents experience psychosocial issues at some point during their growth. The majority of these issues are temporary and generally go unrecognized. It's worth noting that adolescents can have these issues in one situation but not in another (e.g., family, school and friend’s circle). Consequently, these psychiatric morbidities are often misinterpreted. They may be measured intentional or purposefully, their self-esteem may be diminished as a result of social exclusion, sanctions, and criticism. Children and teenagers may be denied help they require due to a faulty and improper understanding of these mental illness. “Adolescence is a critical period characterized by vulnerability to psychological distress, and is therefore an important time for promotion of psychological well-being and early mental health intervention, in order to safeguard against development of mental health issues”.[3]

Adolescence is frequently marked by fresh stress, behavioural changes, and relationship issues, which have an impact on psycho-social development. Adolescent children who have their parents taking part in their life are better able to deal with challenges and maintain their physical and emotional wellbeing. High levels of parental participation and formation of a close relationship between children and parents have been linked to lower rates of depression and loneliness among young people in high-income countries.[4,5,6] The prevalence of mental problems among teenagers attending primary health care institutions in underdeveloped nations ranges from 12 to 29 percent.[7]

.

India accounts for 21% of world's adolescent population. One out of six children affected with psychiatric morbidities. Early Indian community-based studies reported prevalence rate of psychiatric disorders among children ranging from 2.6% to 35.6%.[8] Untreated mental health problems among adolescents may lead to poor school performance, school dropout, strained family relationships, substance abuse, and engaging in risky sexual behaviors.[9] Modern psychiatry still has limitations to access diversity of mind and its functional aspects. Etiopathogenesis of several psychiatric morbidities are still mysterious, and contemporary management is often only partially effective along with lots of adverse effects. Ayurveda Medhya Rasayana are specifically indicated for maintenance of mental/psychological well-being. Several studies also certify that these drugs have nootropic as well as psychotropic effect & work variously to imp. psychological functioning of an individual. Therefore, it is supposed that these drugs can be beneficial in this area also.

Aim and Objective

To evaluate effect of Draksha Samangadi Kashaya Ghan Vati in management of Psychological distress.

Materials and Methods

Study Type: Clinical Study

A Double blind, randomized, placebo-controlled trial was conducted under a strict protocol to prevent bias and to reduce sources of error.

Selection of Cases

Source: In present clinical study total 42 patients were registered under clinical trial from O.P.D./I.P.D., National Institute of Ayurveda, Deemed to be University, Jaipur. and 42 patients were randomly divided into 2 groups. 20 patients in Group A and 22 patients in Group B. Total 40 patients completed trial 2 Subjects discontinued trial from group B.

Inclusion Criteria 

1. Adolescents of age between 13-19 years of either sex.
2. Adolescents having signs and symptoms Psychological distress (DAS).


3. Overtly healthy adolescents.
4. Adolescents whose parents were willing to give consent for clinical trial.

Exclusion Criteria

1. Any past history of diagnosed mental illness.
2. Any severe mental illness requiring hospitalization.
3. Adolescents suffering from major systemic illness necessitating long term treatment like, Known Case of Anaemia, Hypothyroidism and Juvenile Diabetes mellitus.
4. H/o hypersensitivity to any drug.
5. Adolescents whom parents were not willing to give consent for clinical trial.

Withdrawal Criteria

The participant may be withdrawn from the trial if there was:

1. Any major ailment necessitating the institution of new modalities of treatment.
2. Non-compliance of the treatment regimen (minimum 70% compliance was essential to continue in the study).
3. Participant not willing to continue trial.

The decision to withdraw a participant from the trial was taken only by the Principal Investigator, who then have to set out a detailed justification and also indicate the line of further management if was needed. The same needs to the Sponsor and the Ethics Committee within two working days.

Laboratory Investigation (Required to exclude)

Complete Blood Count (CBC), Thyroid Stimulating Hormone (TSH) and Random Blood Sugar (RBS) for exclusion of patients suffering from Chronic Anaemia, Hypothyroidism and Diabetes Mellitus.

Table 1: Showing ingredients of Draksha Samangadi Kashaya Ghan Vati

DrugScientific NameFamilyPart usedDrug Ratio
DrakshaVitis ViniferaVitaceaeFruit1 Part
SamangaRubia cordifoliaRubiaceaeRoot1 Part
GavakshiCirullus colocynthisCucurbitaceaeFruit1 Part
TrayamanaGentina kurrooGentiananaceaRoot1 Part
YashtimadhuGlycyrrihza glabraLeguminosiaeStolon1 Part
ChandanaSantalum albumSantaliaceaeStem1 Part
MarichaPiper nigrumPiparaceaeFruit1/3 Part
Pippali Piper longumPiparaceaeFruit1/3 Part
ShunthiZingiber officinaleZingibaraceaeRhizome1/3 Part

Trial Drug - Draksha Samangadi Kashaya Ghan Vati

Table 2: Showing Grouping and Intervention

Group AGroup B
DrugDraksha Smangadi Kashaya Ghan Vati (Chocolate Coated)Placebo - Chocolate Coated Starch Tablets
No. of Cases2020
Dosage formTablets (250 mg)Tablets (250mg)
Route of administrationOralOral
VehicleWaterWater
Time of administration12 hourly (500 mg/day)12 hourly (500mg/day)
Duration of therapy8 weeks8 weeks
Dose500 mg/day500 mg/day

Follow ups: Every 2 weeks (Day 14th, 28th, 42th and 56th)

Duration of drug administration/ trial: 8 weeks

End Point: Safety and Efficacy

Assessment Criteria

  • Depression, anxiety and stress scale (DASS 42)
  • AyuSoftware Tool for Prakriti assessment

Methods of Assessment

1. Prior to selection - (screening)

  • Informed consent/assent
  • Eligibility evaluation based on survey

2. During selection - (baseline)

  • General information (personal identification and demographic profile).
  • Medical history, general physical and systemic examination.
  • Assessment of psychological distress (DAS).
  • Issue of drugs.
  • Instructions to come after 2 weeks

3. During treatment i.e., on 14th, 28th, 42nd
Assessing drug compliance.

  • Issue of drugs. Instructions to come at each follow up after 2 weeks
  • ADR Assessment

4. At the end of the treatment i.e. at the end of 8 weeks (56th Day)

  • Medical history, general physical and systemic examination.

  • Assessment of Psychological Distress by DASS Score.
  • ADR Assessment

Assessment Tool

Depression, anxiety and stress scale (DASS 42)

Outcome Measures

1. Primary outcome measures

  • Change in depression, anxiety and stress scale (DASS 42) Score.

2. Secondary outcome measures

  • Improvement in total well being.

Adverse Drug Reaction (ADR)

No ADR (Adverse Drug Reaction) was reported during the course of trial. This is confirmed by the ADR certificate with reference number F.NO.-IPvC /NIA/0055/23.

Institutional Ethics Committee Clearance

The ethical approval of the present trial has been taken by the Institutional ethics committee, National Institute of Ayurveda, Jaipur, Order No. IEC/ACA/2021/02-36, dated 01-09-2021.

Clinical Trial Registry of India Registration

Prior to the start of trial, the study was applied for registration in CTRI with reference number REF/2022/03/052596 and in march 2022 trial was registered to CTRI with registration No. CTRI/2022/03/041548.

Data Documentation and Analysis

All information regarding clinical trial were properly documented, carefully handled and meticulously stored in order to ensure its accurate interpretation and verification. Observation documented during the study were analysed and findings were evaluated by using statistical methods.

For Objective parameters: Students - Paired t-Test. For Subjective parameters: - Ordered chi-square test.

Observation and Results

Table 3: Basic details of two groups

VariablesFrequencyPercent
GroupA2050
B2050
Total40100
GenderMale1025
Female3075
Total40100
ReligionHindu3690
Muslim410
Total40100
Economic statusHigh12.5
Middle3895
Low12.5
Total40100
Immunization StatusComplete3280
Incomplete12.5
Unknown717.5
Total40100
HabitatRural820.0
Urban3280.0
Total40100.0
Family TypeNuclear2665
Joint1435
Total40100

Total no. of family member41025
51640
612.5
7820
9410
1112.5
Total40100.0
Diet HabitRegular2357.5
Irregular1742.5
Total40100.0
Type of dietVeg3485.0
Mixed615.0
Total40100.0
Frequency of fast food (time/weeks)125.0
22255.0
31025.0
4410.0
5 or more25.0
Total40100.0
Frequency of carbonated drink (time/week)No25.0
1717.5
21742.5
3820.0
4 or more615.0
Total40100.0
Frequency of tea/coffee (time/days)No717.5
1717.5
2 or more2665.0
Total40100.0
Use of Tobacco, Alcohol, CigaretteNo40100.0
AppetiteNormal2357.5
Increased12.5
Decreased1640.0
Total40100.0
MicturitionNormal3997.5
Reduced12.5
Total40100.0
Bowel HabitRegular3075.0
Irregular1025.0
Total40100.0
Bowel frequencyNormal3075.0
Constipated1025.0
Total40100.0
Pattern of Menstruation Cycle0 (Male)1025.0
Regular2152.5
Irregular922.5
Total40100.0
Dysmenorrhoea0 (Male)1025.0
Yes1537.5
No1537.5
Total40100.0

PrakritiKP922.5
KV1332.5
PK12.5
VK1742.5
Total40100.0
VikritiPrakriti Sam Samvaya40100.0
SaaraAsthi512.5
Mansa37.5
Meda12.5
Rakta615.0
Twak2562.5
Total40100.0
SamhananaMadhyama40100.0
SatmyaMadhyama40100.0
SatvaMadhyama922.5
Avara3177.5
Total40100.0
Ahara ShaktiMadhyama1435.0
Avara2665.0
Total40100.0
Vyayama ShaktiMadhyama1947.5
Avara2152.5
Total40100.0
Drishti (Vision)Normal2972.5
Abnormal1127.5
Total40100.0
SleepNormal3587.5
Disturbed512.5
Total40100.0

Table 4: Comparative Distribution of Anthropometric Measures between Group A and Group B

Group AGroup B
Min.Max.Mean ± SDMin.Max.Mean ± SD
Age (years)131715.25±1.118131815.20±1.281
Weight (kg)36.474.047.125±9.85029.954.342.505±6.572
Height (CM)140.0177.0159.240±8.740143.0174.0156.200±7.466
BMI13.524.418.485±3.17613.821.317.360±1.837

Table 5: Comparative Distribution of Treatment Effects on Depression, Anxiety, and Stress Levels in Group A and Group B

GradeGroup AGroup B
Before TreatmentAfter Treatmentp valueBefore TreatmentAfter Treatmentp value
Depression1 (Normal)590.0025110.162
2 (Mild)21077
3 (Moderate)8152
4 (Severe)4010
5 (Extremely severe)1020
Anxiety1 (Normal)380.0005260.121
2 (Mild)1668
3 (Moderate)3655
4 (Severe)5031
5 (Extremely severe)8040

Stress1 (Normal)2140.0007590.058
2 (Mild)6348
3 (Moderate)6393
4 (Severe)6020
5 (Extremely severe)0000

Ordered chi-square test of independence

There are varying degrees of improvement across the different psychological conditions and groups. In terms of Depression, participants in Group A demonstrated a statistically significant improvement (p = 0.002). Conversely, the change in Group B, though positive, was not statistically significant (p = 0.162). Similarly, when considering Anxiety levels, participants in both Group A and Group B showed noteworthy improvements post-treatment. Group A exhibited a highly significant reduction (p = 0.0005). In contrast, Group B experienced though the effect did not reach statistical significance (p = 0.121).

For Stress levels, participants in both groups displayed improvements, but the changes were more pronounced in Group A. Group A experienced a highly significant reduction in stress levels (p = 0.0007). Group B, on the other hand, which was not statistically significant (p = 0.058). Group A consistently shows significant improvements across all three psychological conditions (Depression, Anxiety, and Stress) compared to Group B. Specifically, Group A experiences statistically significant reductions in scores for Depression (p = 0.002), Anxiety (p = 0.0005), and Stress (p = 0.0007) after treatment. In contrast, while Group B also shows positive changes, these improvements do not reach statistical significance for any of the three conditions. Overall, the data suggests that Group A responds more favourably to the treatment in comparison to Group B.

Discussion

In the present study, for internal use, Draksha Smangadi Kashaya Ghan Vati was selected for oral route of administration. The effect attained by the study drug can be explained by multiple mechanism. The ingredients of Draksha Smangadi Kashaya Ghan Vati have predominantly Laghu, Tikshna, Ruksha, Snigdha and Sara Guna. Laghu Guna is explained to be similar in property with Satva Guna which improves the persons stress tolerance levels.

Tikshna and Ruksha Guna by virtue of their characteristics removes the obstruction in Manovaha Srotas caused vitiated Kapha Dosha. Snigdha Guna nourishes the Tarpaka Kapha which help the proper functioning Indriyas (Sense organs). Sara Guna improves the emotional and thought aspects and improves the insight of the recipients. Analysis of Rasa of the drugs depicts that majority of the drugs possesses Katu and Tikata Rasa which helps in Pachana of Ama dosha and at the same time pacified vitiated Kapha Dosha. Also, some drugs possess Madhrua Rasa which does Shadindriye Prasadana and also acts a Medhya.

Considering the Vipaka of all ingredients of study drug, 50% drugs have Madhura Vipaka and 50% have Katu Vipka. Madhura Vipaka is said to increase all the Sharira Dhatus, including the brain tissue, nourishes the Mana and Indriyas. Thus, it can be assumed that it has nourishing effect on the brain. Katu Vipaka on the other hand increases the overall metabolism in the body including the brain, helps in absorption of nutrients, thereby reducing nutrients deficiency and stimulates all sense organs to perceive their functions normally.

Vishada and Chittodvega is described as the state of elevated Vata and Kapha dosha. The vitiated Kapha dosha does the Avarana of Vata Dosha which in turn leads to improper functioning of Vata. The study drug is mainly Kapha-Vata Shamaka property and removes the vitiated Kapha Dosha Avarana and clears the channels for proper functioning of Vata Dosha. Also vitiated Kapha Dosha impairs the functioning of Sadhaka Pitta. Once this Vata Dosha gets normal, it helps in normal perception of environmental inputs which leads to proper acquisition of knowledge. As the knowledge is acquired accordingly the level of anxiety and stress is decreased and the confidence levels are improved.

Drugs like Pippali and Yasthimadhu in the study drug are proven Medhya drugs. These drugs through their properties improves the cognition and perception in the brain tissues and acts as nootropic drugs. These drugs improve the analysis aspect of the brain and improve tolerance state of brain.


Majority of constituents of study drug possess Rasayana property. By virtue of this property the study drug nourishes all the Dhatu in the body including the brain tissues. As the brain tissues are nourished their potency improves and the cognition is improved.

Trikatu is a known drug which possess Deepana and Pachana property. This property results in the improvement of Jatharagni (metabolism) which does the proper assimilation of food. As the food is properly digested the forming Dhatu will be of optimum quality. Also, Trikatu (Pippali, Shunthi and Maricha) improves the bioavailability of the drugs and helps in proper assimilation and absorption of the drug towards the site of action.

Various clinical and experimental study proved that all ingredients of the study drug possess anti-stress, anti-depression, anti-anxiety, nootropic and anti-oxidant properties. By virtue of these properties the study drugs act on the brain tissues and improves the cognition and perception state of the brain. These drugs at the same time improves the learning and memory state of the child which improves their academic performance. As the academic performance is improved the level of associated stress is reduced.

Conclusion

In this study, Group A (Trial drug intervention) consistently showed significant improvements across all three psychological conditions (Depression, Anxiety, and Stress) compared to Group B. Specifically, Group A experiences statistically significant reductions in scores for Depression (p = 0.002), Anxiety (p = 0.0005), and Stress (p = 0.0007) after treatment. In contrast, while Group B (placebo group) also showed positive changes, these improvements do not reach statistical significance for any of the three conditions. Therefore, it can be concluded that Draksha Smangadi Kashaya Ghan Vati (Chocolate Coated) is effective in the management of Psychological Distress in Adolescents.

References

1. Pandit Rajeshwardutta Shastri editor. Charakasamhita Chikitsasthan by Agnivesh (vidhyotini hindi commentary);2011; Rasayanaadhyaya 1/3-30-31

2. https://depts.washington.edu/ dbpeds/ Screening% 20 Tools/ Strengths _ and _ Difficultie s_ Questionnaire. pdf. (Accessed January 2020).

3. Goodman R. Psychometric properties of the strengths and difficulties questionnaire. J Am Acad Child Adolesc Psychiatry. 2001;40(11): 1337-1345.

4. Swedish National Institute of Public Health. Tips and guidance for the treatment of mental anguish, mental suffering and mental illness - A professional consultation, Survey of mental health among children and adolescents. Swedish National Institute of Public Health, 31 October 2013; 201

5. Sommers I, Baskin DR. The situational context of violent female offending. Journal of Research in Crime and Delinquency.1993; 30(2):136-162.

6. Rehman R, Singh H. Family type and adjustment level of adolescents: A Study. Int J Dent Med Res 2015;1(6):22-25. 10.

Disclaimer / Publisher's Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of Journals and/or the editor(s). Journals and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.